5-氨基酮戊酸在光动力和声动力治疗肿瘤中的实验与临床研究进展

临床肿瘤学杂志

5-氨基酮戊酸在光动力和声动力治疗肿瘤中的实验与临床研究进展

许桐瑛，朱文婷，谢蕊，魏孝礼，李燕京，白玉贤

150081 哈尔滨哈尔滨医科大学附属肿瘤医院消化内科

收稿日期:2016-01-08 修回日期:2016-02-18 出版日期:2016-05-31 发布日期:2016-05-31
通讯作者: 白玉贤

Progession of the experimental and clinical research of 5-aminolevulinic acidbased photodynamic and sonodynamic therapy of tumor

XU Tongying， ZHU Wenting， XIE Rui， WEI Xiaoli， LI Yanjing， BAI Yuxian.

Department of Gastroenterology， Cancer Hospital Affiliated to Harbin Medical University， Harbin 150081， China

Received:2016-01-08 Revised:2016-02-18 Online:2016-05-31 Published:2016-05-31
Contact: BAI Yuxian

摘要/Abstract

摘要： 5-氨基酮戊酸（5-aminolevulinic acid，5-ALA）作为光敏剂、声敏剂已广泛应用于光动力疗法和声动力疗法中。5-ALA通过细胞内代谢产生原卟啉Ⅸ（Protoporphyrin Ⅸ，PpⅨ），其具有的光敏性和声敏性可以在激光和超声作用下激活，产生氧自由基或活性氧物质，诱导细胞凋亡、坏死。本文就近年来5-ALA在光、声动力疗法治疗肿瘤中的实验与临床研究进展作一综述。

Abstract: 5-aminolevulinic acid（5-ALA） is a strong photosensitizer， and it is widely used in photodynamic and sonodynamic therapy. 5-ALA is a precursor of PpⅨ which is generally accumulated higher in tumor cells than normal cells. Irradiation and ultrasound irradiation excitate PpⅨ in tumor cells and produce reactive oxygen species（ROS）， and damage DNA， mitochondria membrane and the other cell membrane then causes the apoptosis， necrosis. This article reviews the experimental and clinical research progression of 5-ALA in photodynamic and sonodynamic therapy of tumor recent years.

许桐瑛，朱文婷，谢蕊，魏孝礼，李燕京，白玉贤

. 5-氨基酮戊酸在光动力和声动力治疗肿瘤中的实验与临床研究进展[J]. 临床肿瘤学杂志, 2016, 21(5): 469-.

XU Tongying， ZHU Wenting， XIE Rui， WEI Xiaoli， LI Yanjing， BAI Yuxian.

. Progession of the experimental and clinical research of 5-aminolevulinic acidbased photodynamic and sonodynamic therapy of tumor[J]. Chinese Clinical Oncology, 2016, 21(5): 469-.

参考文献

Metrics

Viewed

Full text

Abstract

Cited

Shared

Discussed